Matches in SemOpenAlex for { <https://semopenalex.org/work/W1572163062> ?p ?o ?g. }
- W1572163062 abstract "Chronic granulomatous disease (CGD) is a rare primary immunodeficiency syndrome characterized by mutations in one of the four genes that encode the subunits of NADPH oxidase, a enzyme principally involved in the ROS mediated pathogen killing. The patients are characterized by life-threatening and recurrent infections mainly by catalase-positive microorganisms, due to the inability of their phagocytes to express a respiratory burst against invading bacteria (e.g. Staphylococcus aureus) and fungi (e.g. Aspergillus fumigatus and Candida albicans). Patients, also suffer from a variety of sterile inflammatory conditions as acute and/or chronic inflammation with fibrosis containing non-caseous granulomas in the intestinal tract, liver, lymph nodes, urogenital tract, skin, and brain, most probably caused by an intrinsic dysregulation of the inflammatory mechanisms that can involve other cell types than the known defective phagocytes.Although in literature there are few immunological studies about cell function in CGD, a recent work on CGD animal model, has highlighted that in acute fungal infection, a dysregulation of IL-17-secreting cells, coupled with a decrease IFN-γ-producing effector cells and of IL-10-producing regulatory cells, could have a pathogenic role. Moreover, a decreased frequency of a specific T lymphocytes compartment, called Th17, for their characteristic IL-17A production, was associated with increased susceptibility to fungal end bacterial infection in several human chronic disease as hyper IgE syndrome (HIES) and chronic mucocutaneous candidiasis.In this study, we have investigated the potential involvement of T lymphocyte deregulation in CGD manifestations, by comparison of proliferation, mRNA expression, cytokine production and T lymphocyte phenotype upon fungal and bacterial antigen stimulation, of peripheral blood mononuclear cells (PBMC) between a cohort of CGD patients and of healthy controls.Despite a very large variability in functional responses found in both patient and controls, we showed a statistical significant increased of proliferation upon C. albicans lysate and of IL-10 production upon A. fumigatus in CGD patients, coupled with a slight increase of IFN-γ and IL-17A upon fungal stimulation.Furthermore, upon A. fumigatus in the CDG cohort was found a statistically significant increased of IL-17A production, excluded one patient with chronic inflammation, and increased IL-17A mRNA expression, in agreement with an involvement of IL-17A+ cells in CGD pathogenesis, as shown by the CGD animal model of invasive aspergillosis.We also observed that, in agreement with a protective role of IFN-γ, CGD patients that experienced severe aspergillosis expressed low IFN-γ production compared with other patients, but similar to controls, while patient that not experienced severe aspergillosis had increased IFN-γ production compared to controls, demonstrating that a compensatory IFN-γ increased was need to protect patients with defect of ROS-mediated killing. Concerning the responses to C. albicans yeast and hyphae stimulation, we observed similar amount of IFN-γ and increased of IL-17A and IL-10 levels, compared to controls, showing that probably different pathological mechanism lead to increased Candida albicans infections in CGD with respect to HIES, because it would not be dependent on a decrease of IL17A response to fungal antigens.Moreover, in comparison to CGD patients, HIES patients expressed lower value of IFN-γ for all antigens, but differently to STAT3-mutated HIES patient, that not express IL-17A upon all kinds of stimulation, in STAT3-wt HIES patient IL-17A production upon both C. albicans yeast and hyphae was similar to CGD and increased compared to age-matched healthy controls. Thus the reduced frequencies of C. albicans infection in CGD compared to STAT3-wt HIES, may be explained through the main protective level of IFN-γ. Moreover we believe that in vitro immunological test can help us to exclude a STAT3 mutation, in patients who have a positive score for HIES, before performing a molecular analysis of the gene." @default.
- W1572163062 created "2016-06-24" @default.
- W1572163062 creator A5011283417 @default.
- W1572163062 date "2010-06-14" @default.
- W1572163062 modified "2023-09-26" @default.
- W1572163062 title "Adaptive immunity in a human chronic inflammatory disorder: phenotypic and functional characterization of T lymphocytes in a cohort of Chronic Granulomatous Disease patients" @default.
- W1572163062 cites W138780577 @default.
- W1572163062 cites W1510477151 @default.
- W1572163062 cites W1517631297 @default.
- W1572163062 cites W1537128240 @default.
- W1572163062 cites W1537303659 @default.
- W1572163062 cites W1541303588 @default.
- W1572163062 cites W1543728556 @default.
- W1572163062 cites W1553227656 @default.
- W1572163062 cites W1591445937 @default.
- W1572163062 cites W1839240500 @default.
- W1572163062 cites W1899583926 @default.
- W1572163062 cites W1952088202 @default.
- W1572163062 cites W1968212813 @default.
- W1572163062 cites W1970935798 @default.
- W1572163062 cites W1972041066 @default.
- W1572163062 cites W1975253464 @default.
- W1572163062 cites W1977609087 @default.
- W1572163062 cites W1978174410 @default.
- W1572163062 cites W1981713966 @default.
- W1572163062 cites W1982926364 @default.
- W1572163062 cites W1986920071 @default.
- W1572163062 cites W1988443097 @default.
- W1572163062 cites W1990708747 @default.
- W1572163062 cites W1992774063 @default.
- W1572163062 cites W1998596519 @default.
- W1572163062 cites W1998805394 @default.
- W1572163062 cites W2000346726 @default.
- W1572163062 cites W2000427783 @default.
- W1572163062 cites W2001682932 @default.
- W1572163062 cites W2001981959 @default.
- W1572163062 cites W2002726823 @default.
- W1572163062 cites W2008713912 @default.
- W1572163062 cites W2008981570 @default.
- W1572163062 cites W2009669995 @default.
- W1572163062 cites W2010585679 @default.
- W1572163062 cites W2010595044 @default.
- W1572163062 cites W2010630254 @default.
- W1572163062 cites W2012680181 @default.
- W1572163062 cites W2013005096 @default.
- W1572163062 cites W2013566990 @default.
- W1572163062 cites W2014750930 @default.
- W1572163062 cites W2014785961 @default.
- W1572163062 cites W2017443683 @default.
- W1572163062 cites W2019475419 @default.
- W1572163062 cites W2019640011 @default.
- W1572163062 cites W2026274426 @default.
- W1572163062 cites W2029387145 @default.
- W1572163062 cites W2030225423 @default.
- W1572163062 cites W2031241507 @default.
- W1572163062 cites W2032327249 @default.
- W1572163062 cites W2035183484 @default.
- W1572163062 cites W2035644849 @default.
- W1572163062 cites W2037303082 @default.
- W1572163062 cites W2038753879 @default.
- W1572163062 cites W2040024690 @default.
- W1572163062 cites W2040636315 @default.
- W1572163062 cites W2043500875 @default.
- W1572163062 cites W2044063309 @default.
- W1572163062 cites W2044682638 @default.
- W1572163062 cites W2045121461 @default.
- W1572163062 cites W2050152285 @default.
- W1572163062 cites W2050719029 @default.
- W1572163062 cites W2051018333 @default.
- W1572163062 cites W2051687661 @default.
- W1572163062 cites W2054869955 @default.
- W1572163062 cites W2056548985 @default.
- W1572163062 cites W2057098678 @default.
- W1572163062 cites W2058505728 @default.
- W1572163062 cites W2059710782 @default.
- W1572163062 cites W2060168659 @default.
- W1572163062 cites W2060224232 @default.
- W1572163062 cites W2060762539 @default.
- W1572163062 cites W2060924363 @default.
- W1572163062 cites W2064811541 @default.
- W1572163062 cites W2071673910 @default.
- W1572163062 cites W2071883240 @default.
- W1572163062 cites W2072862372 @default.
- W1572163062 cites W2075195835 @default.
- W1572163062 cites W2076889715 @default.
- W1572163062 cites W2079527931 @default.
- W1572163062 cites W2083020576 @default.
- W1572163062 cites W2083042824 @default.
- W1572163062 cites W2084509745 @default.
- W1572163062 cites W2085321949 @default.
- W1572163062 cites W2086264253 @default.
- W1572163062 cites W2087905758 @default.
- W1572163062 cites W2088164656 @default.
- W1572163062 cites W2090819877 @default.
- W1572163062 cites W2092415828 @default.
- W1572163062 cites W2092565908 @default.
- W1572163062 cites W2094516448 @default.
- W1572163062 cites W2094786750 @default.
- W1572163062 cites W2100990607 @default.
- W1572163062 cites W2101745219 @default.